PT2401373E - Apresentação em pix de fago independente de sequência sinal - Google Patents

Apresentação em pix de fago independente de sequência sinal

Info

Publication number
PT2401373E
PT2401373E PT107074932T PT10707493T PT2401373E PT 2401373 E PT2401373 E PT 2401373E PT 107074932 T PT107074932 T PT 107074932T PT 10707493 T PT10707493 T PT 10707493T PT 2401373 E PT2401373 E PT 2401373E
Authority
PT
Portugal
Prior art keywords
phage display
signal sequence
pix phage
phagemid
display system
Prior art date
Application number
PT107074932T
Other languages
English (en)
Inventor
Geir Age Loeset
Original Assignee
Nextera As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nextera As filed Critical Nextera As
Publication of PT2401373E publication Critical patent/PT2401373E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1037Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K19/00Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT107074932T 2009-02-25 2010-02-24 Apresentação em pix de fago independente de sequência sinal PT2401373E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15543709P 2009-02-25 2009-02-25
DKPA200900666 2009-05-28

Publications (1)

Publication Number Publication Date
PT2401373E true PT2401373E (pt) 2013-12-16

Family

ID=42154513

Family Applications (1)

Application Number Title Priority Date Filing Date
PT107074932T PT2401373E (pt) 2009-02-25 2010-02-24 Apresentação em pix de fago independente de sequência sinal

Country Status (14)

Country Link
US (1) US8946128B2 (pt)
EP (1) EP2401373B1 (pt)
JP (1) JP5745432B2 (pt)
KR (1) KR101698884B1 (pt)
CN (2) CN104017778A (pt)
AU (1) AU2010217551B2 (pt)
CA (1) CA2753782C (pt)
DK (1) DK2401373T3 (pt)
ES (1) ES2438783T3 (pt)
PL (1) PL2401373T3 (pt)
PT (1) PT2401373E (pt)
RU (1) RU2540010C2 (pt)
SI (1) SI2401373T1 (pt)
WO (1) WO2010097411A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008290537B2 (en) 2007-08-20 2014-04-03 Nextera As pVII phage display
US9598692B2 (en) 2009-09-25 2017-03-21 University Of Oslo Multivalent phage display systems and methods
CN105754958B (zh) * 2016-03-07 2019-05-07 中国科学院广州生物医药与健康研究院 一种可投送自主发光元件的分枝杆菌噬菌体及其应用
GB201718294D0 (en) * 2017-11-03 2017-12-20 Nextera As Vector construct

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6472147B1 (en) * 1999-05-25 2002-10-29 The Scripps Research Institute Methods for display of heterodimeric proteins on filamentous phage using pVII and pIX, compositions, vectors and combinatorial libraries
US7037706B1 (en) 1999-09-29 2006-05-02 Xenoport, Inc. Compounds displayed on replicable genetic packages and methods of using same
US7094579B2 (en) * 2002-02-13 2006-08-22 Xoma Technology Ltd. Eukaryotic signal sequences for prokaryotic expression
US20060252028A1 (en) * 2002-08-16 2006-11-09 Hiroshi Ueda Method of assaying interaction between proteins
DE10256669B4 (de) 2002-12-04 2006-03-09 Universitätsklinikum Charité an der Humboldt-Universität zu Berlin Technologietransferstelle Gemisch mindestens zweier Fusionsproteine sowie ihre Herstellung und Verwendung
US20060068421A1 (en) 2004-08-05 2006-03-30 Biosite, Inc. Compositions and methods for phage display of polypeptides
AU2008290537B2 (en) 2007-08-20 2014-04-03 Nextera As pVII phage display
ES2564523T3 (es) 2007-12-19 2016-03-23 Janssen Biotech, Inc. Diseño y generación de bibliotecas de presentación en fago por pIX de novo humanas mediante fusión con pIX o pVII, vectores, anticuerpos y métodos
NZ590343A (en) * 2008-07-18 2012-10-26 Bristol Myers Squibb Co Compositions monovalent for cd28 binding and methods of use

Also Published As

Publication number Publication date
DK2401373T3 (da) 2013-10-21
RU2011135624A (ru) 2013-04-10
CN102361980B (zh) 2014-06-18
AU2010217551A1 (en) 2011-09-08
EP2401373B1 (en) 2013-09-11
ES2438783T3 (es) 2014-01-20
AU2010217551B2 (en) 2014-11-27
CN102361980A (zh) 2012-02-22
WO2010097411A1 (en) 2010-09-02
KR20110119820A (ko) 2011-11-02
RU2540010C2 (ru) 2015-01-27
CA2753782C (en) 2019-04-30
PL2401373T3 (pl) 2014-02-28
CA2753782A1 (en) 2010-09-02
EP2401373A1 (en) 2012-01-04
US8946128B2 (en) 2015-02-03
JP2012518423A (ja) 2012-08-16
SI2401373T1 (sl) 2014-02-28
KR101698884B1 (ko) 2017-01-23
CN104017778A (zh) 2014-09-03
US20110301064A1 (en) 2011-12-08
JP5745432B2 (ja) 2015-07-08

Similar Documents

Publication Publication Date Title
PT2401373E (pt) Apresentação em pix de fago independente de sequência sinal
HK1122839A1 (en) Phage display using contranslational translocation of fusion polypeptides
NZ736022A (en) De novo binding domain containing polypeptides and uses thereof
CL2008000664A1 (es) Proteina aislada que comprende un polipeptido del receptor iib de una variante de activina; acido nucleico aislado; vector recombinante que comprende dicho acido nucleico; celula huesped; composicion farmaceutica que comprende dicha proteina; uso de
PH12015502849A1 (en) Biomarkers for cognitive dysfunction diseases and method for detecting cognitive dysfunction disease using biomarkers
MA33213B1 (fr) Anticorps antagoniste specifique d'un heterodimere alpha-4-beta-7
WO2011116226A3 (en) Display of antibody fragments on virus-like particles of rna bacteriophages
MX355010B (es) Dispositivo y metodo para determinar informacion relacionada con un dispositivo medico.
IL206409A0 (en) ALTERNATIVE SCAFFOLD PROTEIN FUSIONS PHAGE DISPLAY VIA FUSION TO pIX OF M13 PHAGE
WO2012158964A3 (en) Improved peptide pharmaceuticals for osteoporosis
ATE514783T1 (de) Plasmidsystem zur expression mehrerer gene
WO2010033229A3 (en) Methods and vectors for display of 2g12 -derived domain exchanged antibodies
DK2450815T3 (da) Fremgangsmåde til at identificere peptider og proteiner ud fra massespektrometri-data
WO2009085468A3 (en) A human non-antibody peptide or protein phage library
EP4297036A3 (en) Method for predicting the off-target binding of a peptide which binds to a target peptide presented by a major histocompatibility complex
MX354516B (es) Vectores que codifican el factor de viabilidad de conos derivado de bastones.
EP3927720A4 (en) LINKER AND METHODS FOR OPTICAL DETECTION AND SEQUENCING
WO2012162373A8 (en) Ros kinase in lung cancer
DE60334466D1 (de) Entkopplung von dna-propagierung und proteinexpression für phagen-display
WO2011036666A3 (en) Systems and methods for measuring translation of target proteins in cells
EP3962930A4 (en) METHODS AND REAGENTS FOR CLEAVING THE N-TERMINAL AMINO ACID FROM A POLYPEPTIDE
EP1820019A4 (en) METHOD FOR MEASURING BETA-AMYLOID PEPTIDES
JP2011004734A5 (pt)
WO2009108716A3 (en) Synthetic peptides
WO2011035067A3 (en) Isolated australian coral reef fluorescent proteins and cell-based kinase or phosphatase platforms for cancer drug development